What is the equity of Zoetis this year?
Zoetis has equity of 5 B USD this year.
Zoetis Equity 2024
Zoetis Equity
5 B USD
Ticker
ZTS
ISIN
US98978V1035
WKN
A1KBYX
In 2024, Zoetis's equity was 5 B USD, a 13.44% increase from the 4.41 B USD equity in the previous year.
Zoetis Aktienanalyse
What does Zoetis do?
Zoetis Inc. is a leading company in the development and marketing of animal health technology and solutions. The company specializes in innovative products for animals such as dairy cattle, pigs, poultry, dogs, cats, and horses. Zoetis was founded in 1952 as a subsidiary of Pfizer and operated as Pfizer Animal Health. In 2013, the company was finally spun off from Pfizer and became Zoetis Inc. Zoetis focuses on the development, manufacturing, and marketing of products for livestock and pets, including vaccines, pharmaceuticals, biological therapies, and diagnostics. The company operates globally and has its headquarters in Parsippany, New Jersey. Zoetis' business model consists of various business segments divided into animal categories: cattle, pigs, poultry, pets, and horses. Each of these business segments offers specialized solutions for animal owners and veterinarians. In the cattle products segment, Zoetis offers products for dairy cows, beef cattle, and calves. They also provide a variety of prevention and treatment solutions for major animal health issues such as mastitis, reproductive disorders, and respiratory problems. In the swine segment, Zoetis offers prevention and treatment solutions for infectious diseases and parasite control. They also provide products for promoting swine health and weight gain. In the poultry segment, Zoetis offers solutions for the prevention and treatment of infectious diseases. The company's products aim to improve animal health, productivity, and efficiency. Zoetis also offers products for the pet segment, including vaccines, pharmaceuticals, and therapies for dogs, cats, and other pets. Here, the company also provides solutions for major health issues such as heart diseases, pain management, and parasite control. In the horse segment, Zoetis offers solutions for the prevention and treatment of diseases such as equine rhinopneumonia, worm infestations, and arthritis. They also provide products for promoting horse health and performance. Zoetis is known for a variety of innovative products used by animal owners and veterinarians worldwide. One example is ScourGuard® 4KC, a vaccine that protects calves from diarrheal diseases caused by common bacteria. This vaccine has already proven to be highly effective in controlling bowel diseases in calves. Zoetis has also developed and marketed the first FDA-approved product for pain management in dogs (Rimadyl®), as well as the first licensed product for the treatment of giardia in dogs (Panacur®). In summary, Zoetis, as a global leader in the animal health industry, puts innovation and quality at the forefront. With a wide range of products and solutions in various animal categories, Zoetis is a key player in the animal health industry. Zoetis ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Zoetis's Equity
Zoetis's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Zoetis's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Zoetis's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Zoetis's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Zoetis’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Zoetis stock
What was the equity of Zoetis compared to the previous year?
The equity of Zoetis has increased/decreased by 13.44% increased compared to the previous year.
What impact does a high equity have on investors of Zoetis?
A high equity is advantageous for investors of Zoetis as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Zoetis?
A low equity can be a risk for investors of Zoetis, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Zoetis affect the company?
An increase in equity of Zoetis can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Zoetis affect the company?
A reduction in equity of Zoetis can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Zoetis?
Some factors that can affect the equity of Zoetis include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Zoetis so important for investors?
The equity of Zoetis is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Zoetis take to change the equity?
To change equity, Zoetis can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Zoetis pay?
Over the past 12 months, Zoetis paid a dividend of 1.5 USD . This corresponds to a dividend yield of about 0.86 %. For the coming 12 months, Zoetis is expected to pay a dividend of 2.03 USD.
What is the dividend yield of Zoetis?
The current dividend yield of Zoetis is 0.86 %.
When does Zoetis pay dividends?
Zoetis pays a quarterly dividend. This is distributed in the months of February, May, August, November.
How secure is the dividend of Zoetis?
Zoetis paid dividends every year for the past 18 years.
What is the dividend of Zoetis?
For the upcoming 12 months, dividends amounting to 2.03 USD are expected. This corresponds to a dividend yield of 1.16 %.
In which sector is Zoetis located?
Zoetis is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zoetis kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zoetis from 12/3/2024 amounting to 0.432 USD, you needed to have the stock in your portfolio before the ex-date on 10/31/2024.
When did Zoetis pay the last dividend?
The last dividend was paid out on 12/3/2024.
What was the dividend of Zoetis in the year 2023?
In the year 2023, Zoetis distributed 1.3 USD as dividends.
In which currency does Zoetis pay out the dividend?
The dividends of Zoetis are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Zoetis stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank
Andere Kennzahlen von Zoetis
Our stock analysis for Zoetis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zoetis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
